American Oncology Network, Inc.
AONCWDrugs in Pipeline
10
Phase 3 Programs
9
Upcoming Catalysts
1
Next Catalyst
Jan 2027
Market Overview
Stock performance and key metrics
1 upcoming, 0 past
Exemestane
Breast Adenocarcinoma
Standard Medical Care (SMC)
Anemia
Ferric Carboxymaltose
Heart Failure
Injectafer
Cancer and Chemotherapy Related Anemia
Ferric Carboxymaltose (FCM)
Iron Deficiency Anemia
Venofer
Anemia
Ferrous Sulfate tablets
Postpartum Anemia
Zoledronic Acid
Giant Cell Tumor of Bone
tamoxifen citrate
Breast Cancer
Taxoprexin
Metastatic Melanoma
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Exemestane | Phase 3 | Breast Adenocarcinoma | - | - |
Standard Medical Care (SMC) | Phase 3 | Anemia | - | - |
Ferric Carboxymaltose | Phase 3 | Heart Failure | - | - |
Injectafer | Phase 3 | Cancer and Chemotherapy Related Anemia | - | - |
Ferric Carboxymaltose (FCM) | Phase 3 | Iron Deficiency Anemia | - | - |
Venofer | Phase 3 | Anemia | - | - |
Ferrous Sulfate tablets | Phase 3 | Postpartum Anemia | - | - |
Zoledronic Acid | Phase 3 | Giant Cell Tumor of Bone | - | - |
tamoxifen citrate | Phase 3 | Breast Cancer | - | - |
Taxoprexin | Phase 2 | Metastatic Melanoma | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in American Oncology Network, Inc.'s drug pipeline?→
CatalystAlert tracks 10 drug candidates in American Oncology Network, Inc.'s (AONCW) pipeline across Phase 3, Phase 2. Its lead program is Exemestane (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is American Oncology Network, Inc.'s next FDA catalyst?→
American Oncology Network, Inc.'s (AONCW) next tracked catalyst is a Phase 3 expected January 15, 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track AONCW biotech catalysts?→
Add AONCW to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow American Oncology Network, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.